Mode
Text Size
Log in / Sign up

Observational study finds lower delayed recall ratios in multiple sclerosis patients versus controls

Observational study finds lower delayed recall ratios in multiple sclerosis patients versus controls
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider long-delay recall tests for cognitive impairment in multiple sclerosis; observational evidence limits causal inference.

This publication is an abstract of an observational study involving 127 participants, comprising 62 patients with multiple sclerosis and 65 age-, sex-, and education-matched healthy controls. The study assessed memory recall immediately, after 30 minutes, and after 7 days using the QRAVLT and QWMS tests. No setting was reported. Follow-up duration was not reported beyond the recall intervals.

Primary outcomes indicated lower recall ratios in multiple sclerosis patients compared to controls. The QRAVLT ratio was 0.64 [95% CI 0.59-0.69] versus 0.78 [0.73-0.82], with p < 0.001. The QWMS ratio was 0.79 [95% CI 0.74-0.84] versus 0.95 [0.90-1.00], also with p < 0.001. These differences were statistically significant and clinically relevant.

Diagnostic performance using the Combined ALF score moderately discriminated subjective memory impairment, yielding an AUC 0.74 with sensitivity 0.73 and specificity 0.73. Lower scores associated with greater fatigue, higher memory complaints, longer disease duration, older age, and greater disability. Safety data were not reported. Associations were observed between lower scores and clinical factors.

The authors note long-delay recall using RAVLT and WMS-IV Logical Memory subtest may improve cognitive impairment detection in multiple sclerosis. As this is an observational study, associations are reported, not causation. Evidence is based on an abstract only. Limitations were not reported. Funding or conflicts were not reported. Clinical application requires caution due to observational design.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: Accelerated long-term forgetting (ALF), defined as an increased rate of memory loss over extended intervals, has so far been detected in a pilot study of patients with mild multiple sclerosis (MS). This study aimed to (I) confirm the presence of ALF in a larger, heterogeneous MS sample, (II) explore associations with patient-reported outcomes, and (III) assess the diagnostic performance of ALF tests for subjective memory impairment. Methods: This study compared 62 MS patients and 65 age-, sex-, and education-matched healthy controls using standardized memory tests (RAVLT, WMS IV-Logical Memory subtest). Recall was assessed immediately, after 30 minutes, and after 7 days. Seven-day/30-minute recall ratios (QRAVLT, QWMS) served as primary outcomes. Self-report measures included memory complaints, fatigue, depression, and sleep disturbances. Linear regression and Receiver operating characteristic (ROC) analyses assessed predictors and diagnostic accuracy. Results: ALF was observed in multiple sclerosis since QRAVLT was lower in patients than in controls (0.64 [95% CI 0.59-0.69] vs. 0.78 [0.73-0.82], p < 0.001), as was QWMS (0.79 [95% CI 0.74-0.84] vs. 0.95 [0.90-1.00], p < 0.001), despite comparable initial learning. Greater fatigue, higher memory complaints, longer disease duration, older age, and greater disability were associated with lower ALF scores. The combined ALF score moderately discriminated subjective memory impairment (AUC 0.74; sensitivity 0.73; specificity 0.73). Conclusion: MS patients showed ALF despite normal initial learning, indicating a specific memory deficit undetected by standard tests. Long-delay recall using RAVLT and WMS-IV Logical Memory subtest may improve cognitive impairment detection in MS.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.